Caxton Associates (UK)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-331,682
Closed -$33.7M 849
2025
Q4
$33.7M Buy
331,682
+327,499
+7,829% +$26.3M 0.66% 22
2025
Q3
$229K Buy
+4,183
New +$209K 0.01% 608

Other funds holding EXAS

Caxton Associates (UK)'s EXAS Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 331,682 shares — an estimated $33.7M sold.

Caxton Associates (UK) first reported a position in EXAS in Q3 2025 and held it in 2 quarters. The position peaked at $33.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 331,682 Exact Sciences shares in Q1 2026, an estimated $33.7M.
  • Caxton Associates (UK) first reported a position in Exact Sciences in Q3 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Exact Sciences position peaked at $33.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.